Antisense Therapeutics Limited's market cap is currently ―. The company's EPS TTM is AU$-0.017; its P/E ratio is -3.59; Antisense Therapeutics Limited is scheduled to report earnings on February 28, 2024, and the estimated EPS forecast is AU$-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 19.23M	AU$ 6.02M	AU$ 4.06M	AU$ 2.90M	AU$ 4.30M
Total Assets	AU$ 22.44M	AU$ 7.00M	AU$ 5.35M	AU$ 3.70M	AU$ 4.80M
Total Debt	AU$ 227.40K	AU$ 306.85K	AU$ 135.26K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -19.01M	AU$ -5.71M	AU$ -3.92M	AU$ -2.90M	AU$ -4.30M
Total Liabilities	AU$ 1.30M	AU$ 1.27M	AU$ 821.23K	AU$ 888.84K	AU$ 580.86K
Stockholders Equity	AU$ 21.14M	AU$ 5.73M	AU$ 4.53M	AU$ 2.81M	AU$ 4.22M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Antisense Therapeutics Limited Earnings and Revenue History

Income Statement >

Antisense Therapeutics Limited Debt to Assets

Balance Sheet >

Antisense Therapeutics Limited Cash Flow

Cash Flow >

Antisense Therapeutics Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing